gamma-H2AX: A potential biomarker in breast cancer

Histone H2AX undergoes phosphorylation as an answer to DNA double-strand breaks, which in turn are part of the oncogenic procedure. The detection of gamma-H2AX can potentially serve as a biomarker for transformation of normal tissue to premalignant and consequently to malignant tissues. The aim of t...

Full description

Saved in:
Bibliographic Details
Main Authors: Palla Viktoria Varvara, Georgios Karaolanis, Christos Valavanis, Gabriela Stanc, Olympia Tzaida, Helen Trihia, Paul Patapis, Dimitrios Dimitroulis, Despoina Perrea
Format: Article
Language:English
Published: SAGE Publishing 2019-09-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428319878536
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850051194803716096
author Palla Viktoria Varvara
Georgios Karaolanis
Christos Valavanis
Gabriela Stanc
Olympia Tzaida
Helen Trihia
Paul Patapis
Dimitrios Dimitroulis
Despoina Perrea
author_facet Palla Viktoria Varvara
Georgios Karaolanis
Christos Valavanis
Gabriela Stanc
Olympia Tzaida
Helen Trihia
Paul Patapis
Dimitrios Dimitroulis
Despoina Perrea
author_sort Palla Viktoria Varvara
collection DOAJ
description Histone H2AX undergoes phosphorylation as an answer to DNA double-strand breaks, which in turn are part of the oncogenic procedure. The detection of gamma-H2AX can potentially serve as a biomarker for transformation of normal tissue to premalignant and consequently to malignant tissues. The aim of this study was to evaluate the clinical significance of gamma-H2AX expression in breast cancer. Gamma-H2AX expression in tissues from 110 breast cancer patients was analyzed by immunohistochemistry and correlated with clinicopathological variables. Greater tumor size, higher grade, and the number of affected lymph nodes are significantly associated with greater values of gamma-H2AX. In addition, gamma-H2AX differs significantly among patients’ International Federation of Gynecology and Obstetrics stage. Higher values of estrogen receptor and progesterone receptor are significantly associated with lower gamma-H2AX values. In conclusion, a positive association between gamma-H2AX expression and infaust histopathological parameters was observed.
format Article
id doaj-art-464aa27e1203410fbf8178b1ecbd095d
institution DOAJ
issn 1423-0380
language English
publishDate 2019-09-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-464aa27e1203410fbf8178b1ecbd095d2025-08-20T02:53:13ZengSAGE PublishingTumor Biology1423-03802019-09-014110.1177/1010428319878536gamma-H2AX: A potential biomarker in breast cancerPalla Viktoria Varvara0Georgios Karaolanis1Christos Valavanis2Gabriela Stanc3Olympia Tzaida4Helen Trihia5Paul Patapis6Dimitrios Dimitroulis7Despoina Perrea8Department of Obstetrics and Gynecology, Diakonie-Klinikum Schwäbisch Hall, Schwäbisch Hall, Germany1st Department of Surgery, Vascular Unit, Laiko General Hospital, Medical School of Athens, Athens, GreeceDepartment of Pathology, Metaxa Cancer Hospital, Piraeus, GreeceDepartment of Pathology, Metaxa Cancer Hospital, Piraeus, GreeceDepartment of Pathology, Metaxa Cancer Hospital, Piraeus, GreeceDepartment of Pathology, Metaxa Cancer Hospital, Piraeus, Greece3rd Department of Surgery, Attikon General Hospital, University of Athens, Athens, Greece2nd Department of Surgery, Laiko Hospital, University of Athens, Athens, Greece2nd Department of Surgery, Laiko Hospital, University of Athens, Athens, GreeceHistone H2AX undergoes phosphorylation as an answer to DNA double-strand breaks, which in turn are part of the oncogenic procedure. The detection of gamma-H2AX can potentially serve as a biomarker for transformation of normal tissue to premalignant and consequently to malignant tissues. The aim of this study was to evaluate the clinical significance of gamma-H2AX expression in breast cancer. Gamma-H2AX expression in tissues from 110 breast cancer patients was analyzed by immunohistochemistry and correlated with clinicopathological variables. Greater tumor size, higher grade, and the number of affected lymph nodes are significantly associated with greater values of gamma-H2AX. In addition, gamma-H2AX differs significantly among patients’ International Federation of Gynecology and Obstetrics stage. Higher values of estrogen receptor and progesterone receptor are significantly associated with lower gamma-H2AX values. In conclusion, a positive association between gamma-H2AX expression and infaust histopathological parameters was observed.https://doi.org/10.1177/1010428319878536
spellingShingle Palla Viktoria Varvara
Georgios Karaolanis
Christos Valavanis
Gabriela Stanc
Olympia Tzaida
Helen Trihia
Paul Patapis
Dimitrios Dimitroulis
Despoina Perrea
gamma-H2AX: A potential biomarker in breast cancer
Tumor Biology
title gamma-H2AX: A potential biomarker in breast cancer
title_full gamma-H2AX: A potential biomarker in breast cancer
title_fullStr gamma-H2AX: A potential biomarker in breast cancer
title_full_unstemmed gamma-H2AX: A potential biomarker in breast cancer
title_short gamma-H2AX: A potential biomarker in breast cancer
title_sort gamma h2ax a potential biomarker in breast cancer
url https://doi.org/10.1177/1010428319878536
work_keys_str_mv AT pallaviktoriavarvara gammah2axapotentialbiomarkerinbreastcancer
AT georgioskaraolanis gammah2axapotentialbiomarkerinbreastcancer
AT christosvalavanis gammah2axapotentialbiomarkerinbreastcancer
AT gabrielastanc gammah2axapotentialbiomarkerinbreastcancer
AT olympiatzaida gammah2axapotentialbiomarkerinbreastcancer
AT helentrihia gammah2axapotentialbiomarkerinbreastcancer
AT paulpatapis gammah2axapotentialbiomarkerinbreastcancer
AT dimitriosdimitroulis gammah2axapotentialbiomarkerinbreastcancer
AT despoinaperrea gammah2axapotentialbiomarkerinbreastcancer